MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0189187
Suvrat Pharmaceuticals Private Limited
Suvrat Pharmaceuticals Private Limited - pharma in Thane, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹61.87 Lakh
▲ 2846% YoY
Net profit · FY 2024
₹41.16 Lakh
Net margin 66.5%
EBITDA · FY 2024
₹41.16 Lakh
EBITDA margin 66.5%
Authorised capital
₹3 Cr
Registered with MCA
Paid-up capital
₹1.51 Cr
Issued & subscribed
Satisfied charges
₹8.5 Cr
No open charges
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
About Suvrat Pharmaceuticals Private Limited
Data last updated:
Suvrat Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 March 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24231MH2006PTC160298. Its GSTIN is 27AAJCS8684E1ZT (Maharashtra).
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹1.51 Cr. It is led by directors Rupali Pravin Kamalapurkar (Managing Director) and Pravin Prabhakarrao Kamalapurkar (Managing Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.87 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹41.16 Lakh (net margin 66.5%) and EBITDA of ₹41.16 Lakh (EBITDA margin 66.5%). Revenue has grown at a compounded annual rate (CAGR) of 149% over three years and 153% over five years.
As per MCA filings, the company has satisfied charges of ₹8.5 Cr on record.
Suvrat Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0189187). The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
CIN U24231MH2006PTC160298
Registration Number 160298
Incorporation Date 06 March 2006
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Non-Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0189187
Key People
Rupali Pravin Kamalapurkar Managing Director Pravin Prabhakarrao Kamalapurkar Managing Director Recognitions & Rankings of Suvrat Pharmaceuticals
Contact details
Suvrat Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressRoom No. 1A Ground Floor Vilas Apartment Sant Tukaram Path Kopri Opp. Mirani Na, Gar, Thane, Maharashtra, India – 400603
- IndustryPharma, API Manufacturers
To see the full contact details of Suvrat Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Suvrat Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Suvrat Pharmaceuticals Private Limited
FY 2024 filings availableSuvrat Pharmaceuticals Private Limited reported revenue of ₹61.87 Lakh (up 2846% YoY) for FY 2024.
Revenue · FY 2024
₹61.87 Lakh ▲ 2846%
Net profit · FY 2024
₹41.16 Lakh margin 66.5%
EBITDA · FY 2024
₹41.16 Lakh margin 66.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 149%
5 years · compounded
▲ 153%
EBITDA CAGR growth
5 years · compounded
▲ 140%
Revenue has grown at a compounded annual rate (CAGR) of 153% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹41.16 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹41.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 66.5% | ||||
| Net Profit Margin | 66.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Suvrat Pharmaceuticals Private Limited, buy the company report.
Board of directors of Suvrat Pharmaceuticals Private Limited
Suvrat Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupali Pravin Kamalapurkar | Managing Director | 06 Mar 2006 | 20 Years 8 Months | Current |
| Pravin Prabhakarrao Kamalapurkar | Managing Director | 06 Mar 2006 | 20 Years 8 Months | Current |
Shareholding
The shareholding of Suvrat Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Suvrat Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹8.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Dec 2014 | 10544036 | State Bank of Hyderabad | ₹8.5 Cr | Satisfied |
To see the full charge records of Suvrat Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Suvrat Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Suvrat Pharmaceuticals Private Limited was last rated by Crisil on 24 Nov 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 24 Nov 2020 |
To see the full credit ratings and regulatory alerts of Suvrat Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Suvrat Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Suvrat Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCS8684E1ZT | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Suvrat Pharmaceuticals Private Limited, buy the company report.
Recent activity
Suvrat Pharmaceuticals Private Limited has 2 board changes on record since 2006: 2 appointments. The latest: Pravin Prabhakarrao Kamalapurkar was appointed as Managing Director on 06 Mar 2006.
AGM
Suvrat Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Suvrat Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai Ii.
Charges
A charge registered on 24 Dec 2014 via Charge ID 10544036 with State Bank Of Hyderabad was fully satisfied on 21 Oct 2023.
Charges
A charge with State Bank Of Hyderabad of Rs. 8.50 Cr registered on 24 Dec 2014 with Charge ID 10544036 was modified on 21 Oct 2015.
Charges
A charge with State Bank Of Hyderabad amounted to Rs. 8.50 Cr with Charge ID 10544036 was registered on 24 Dec 2014.
Appointed
Pravin Prabhakarrao Kamalapurkar was appointed as Managing Director.
Appointed
Rupali Pravin Kamalapurkar was appointed as Managing Director.
Incorporation
06 Mar 2006
Suvrat Pharmaceuticals Private Limited was registered on 06 Mar 2006 with Roc Mumbai Ii & aged 20 years 8 months as per MCA records.
Frequently asked questions
Suvrat Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 March 2006 (20+ years old) and is registered under CIN U24231MH2006PTC160298.
Suvrat Pharmaceuticals has 2 current directors:
- Rupali Pravin Kamalapurkar - Managing Director
- Pravin Prabhakarrao Kamalapurkar - Managing Director
The latest financial statements of Suvrat Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Suvrat Pharmaceuticals is 27AAJCS8684E1ZT, registered in Maharashtra.
The CIN (Corporate Identification Number) of Suvrat Pharmaceuticals is U24231MH2006PTC160298. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Suvrat Pharmaceuticals was incorporated on 06 March 2006, making it 20+ years old. It is registered with the Registrar of Companies, Mumbai.
Pravin Prabhakarrao Kamalapurkar was appointed as Managing Director on 06 Mar 2006. Rupali Pravin Kamalapurkar was appointed as Managing Director on 06 Mar 2006.
Yes, Suvrat Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0189187).
The registered office of Suvrat Pharmaceuticals is at Room No. 1A Ground Floor Vilas Apartment Sant Tukaram Path Kopri Opp. Mirani Na, Gar, Thane, Maharashtra, India – 400603.
Suvrat Pharmaceuticals operates in the pharma industry, in the api manufacturers segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages